2 Non-pharmaceutical ‘Covid shares‘ I like right now

As more positive vaccine news emerges, here are two non-pharmaceutical Covid-19 shares I think will do well next year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The end of the coronavirus seems ever closer. Today, the Oxford-AstraZeneca vaccine added its name to the list of positive results. Moving away from the obvious, however, I think there are a number of non-pharmaceutical that will benefit from the news.

Non-pharm, non-travel, Covid-19 shares

I’m staying away from both pharmaceutical and travel companies. Firstly, the benefits to pharmaceutical companies may seem obvious, but I think they should not. I doubt coronavirus vaccines will make any firm much profit directly, at first. The public outcry and government efforts would make it a PR and moral nightmare. It is likely big-Pharma will have to produce the vaccines for a long time though. When the headlines die down, then they will make money.

As for travel firms, I think the future is far too uncertain. Covid-19 vaccine news may be helping holiday shares, but I think this is too much too soon. The industry could have seen a fundamental change even if and when the coronavirus ends.

With that in mind, here are two non-pharmaceutical, non-travel ‘Covid shares’ I like right now.

BP

My first choice for a stock that will benefit from a vaccine is oil giant BP (LSE: BP). My opinion here is predominantly based on oil prices. The end of Covid-19 will see people begin to travel again. And fear will be removed from the markets. Both these factors benefit oil prices.

The crude oil market does have some underlying weaknesses – namely spare capacity. However, I think major oil producers like Russia and OPEC will self-regulate this to support prices.

Though all oil majors will benefit from stronger crude prices, I think BP is a prime choice as an investment. It is heavily investing in green energy, which should secure its long-term future. In the meantime, it is undergoing some restructuring that will make it more efficient.

What’s more, at current levels it is paying a dividend in the 9% region. Personally, this is my top choice Covid-19 share right now.

HSBC

Again, perhaps not an obvious choice, but let me explain. HSBC (LSE: HSBA), along with most other banks, has put in place large provision for bad loans. These provisions are precautions against potential losses from customers failing to repay loans. The coronavirus, lockdown, and a potential recession brought this about. If a Covid-19 vaccine helps life get back to normal, a recession could be avoided, and shares across the banking sector will benefit.

I should say the possibility of a recession is still far from over, though personally I am optimistic. The Chancellor has already laid out his priority of supporting the economy at the cost of national borrowing. The government will do everything it can to avoid recession.

My choice of HSBC compared to other banks is based on what I consider its underlying strengths. Even aside from a Covid-19 vaccine, it is undergoing a restructuring that will see overheads reduced and (I think) its share price bolstered.

It will be shifting capital from its weaker European and US arms to its main hub in Hong Kong. This is another key component that I think could help its finances over the long term.

I have been bullish on HSBC for quite a while. With some mild reservations about the future of the economy, I think it is one of the cheaper Covid-19 shares worth considering right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Karl has shares in BP and HSBC Holdings. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Up 70% and 80%! I’m thrilled I bought these two red-hot UK stocks exactly 1 year ago

Harvey Jones bought two UK stocks at the end of November last year, and both have smashed the market in…

Read more »

Investing Articles

These FTSE 100 shares could soar over the next year

FTSE 100 shares show strong potential as rate cuts loom. History shows stocks could gain more than 70% in the…

Read more »

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

“If I’d put £5,000 into Santander shares just 2 years ago, here’s what I’d have now”

Our writer considers whether he thinks Santander shares still look good value after a strong period for the global Spanish…

Read more »

Illustration of flames over a black background
Investing Articles

Could this FTSE 250 stock be the next Rolls-Royce?

With an ongoing probe into the motor finance industry, the share price of this member of the FTSE 250 has…

Read more »

Investing Articles

My 3 favourite FTSE dividend stocks give me a mind-blowing 9.82% yield!

Harvey Jones is surprised to learn that he owns the three highest-yielding dividend stocks on the FTSE 100. So is…

Read more »

Investing Articles

Following strong 2024 results, this 6.1%-yielding FTSE 100 gem looks a bargain to me

With good 2024 results delivered, and a buyback and dividend increase announced, this high-yielding FTSE 100 heavyweight looks very cheap…

Read more »

Investing Articles

I’m not surprised the IAG share price is surging, it’s the top-rated UK stock

The IAG share price is up 57% since the start of the year, but remains undervalued. This bull run could…

Read more »

Investing Articles

Is the stock market set for a crash in 2025?

Could antitrust lawsuits derail US tech stocks and cause a stock market crash next year? Stephen Wright thinks the risks…

Read more »